Attributable fraction among the exposed
Attributable Fraction Among the Exposed (AFae), also known as the Risk Attributable to the Exposed, is a measure used in epidemiology to quantify the proportion of disease or health outcomes in the exposed population that can be attributed to a specific exposure. This metric helps in understanding the public health impact of eliminating a particular risk factor among those exposed to it.
Definition
The Attributable Fraction Among the Exposed is defined as the proportion of incidence in the exposed group that is due to the exposure. Mathematically, it can be expressed as:
\[ AFae = \frac{I_e - I_u}{I_e} \]
where \(I_e\) is the incidence in the exposed group, and \(I_u\) is the incidence in the unexposed group. This formula essentially calculates the excess incidence due to exposure among the exposed individuals as a proportion of the total incidence in the exposed group.
Importance
Understanding the AFae is crucial for public health planning and disease prevention strategies. It helps in identifying the potential benefits of removing or reducing exposure to a harmful agent. By quantifying the fraction of disease cases among the exposed that could be prevented, public health officials can prioritize interventions and allocate resources more effectively.
Applications
AFae is widely used in the study of chronic diseases where multiple risk factors are involved, such as cancer, cardiovascular disease, and diabetes. It is also applied in assessing the impact of environmental and occupational exposures on health.
Limitations
While AFae is a valuable tool in epidemiology, it has limitations. It assumes that the exposure is causally related to the disease and that the removal of the exposure would reduce the risk of disease among the exposed. Additionally, AFae does not account for the potential benefits of reducing exposure among the unexposed population.
See Also
This epidemiology-related article is a stub. You can help WikiMD by expanding it.
Attributable fraction among the exposed
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD